October 25, 2020
Business News

Pfizer’s Latest Stealthy Move Could Help It Win the Coronavirus Vaccine Race – Motley Fool

Pfizer(NYSE:PFE) hasn’t been bashful about playing up the prospects for its coronavirus vaccine candidate, BNT162b2, co-developed with BioNTech(NASDAQ:BNTX). The company even predicted that it would be able to submit its investigational vaccine for regulatory review as early as October 2020. Few, if any, of Pfizer’s rivals have been so publicly confident.
But Pfizer hasn’t attempted to draw attention to everything it’s doing on the COVID-19 vaccine front. On the contrary, the big drugmaker is m…

Click here to view the original article.

Related Posts

You might also like ...

post featured image
3 Monster Growth Stocks That Have Legs for Future Gains
post featured image
Grocery stores are preparing for a second wave of panic buying — you should, too – Yahoo! Voices
post featured image
Americans Working From Home Face Internet Usage Limits – The Wall Street Journal